HOW AI-BASED CARDIAC IMAGING COMPLEMENTS CALCIUM SCORING
Webinar with Q&A – Watch Video
In our sixth Transforming Cardiac Care webinar, we compare coronary artery calcium (CAC) scoring with computed tomography angiography (CCTA) enabled by artificial intelligence (AI). Both identify coronary artery disease risk. But while CAC identifies the presence of calcium, AI-enabled CCTA provides comprehensive visualization of both calcified and noncalcified plaque and the severity of stenosis, and it offers the ability to stage and track progression using powerful artificial intelligence. AI-enabled CCTA evolves the CAC approach for a new, higher standard of heart care.
CEO and Founder of The Agatston Center for Preventive Medicine
Dr. Agatston is a world-renowned cardiologist best known for his development of the “Agatston Score” used in CAC testing. He is also an expert in nutrition who authored the best-selling book The South Beach Diet, which together with its companion books have sold more than 23 million copies worldwide. He has authored more than 200 scientific articles and currently serves as professor of medicine at Florida International University Herbert Wertheim College of Medicine, and maintains a private practice in Miami Beach.
Founder and Chief Executive Officer, Cleerly Inc.
Dr. Min is a globally recognized authority on cardiovascular imaging and physician scientist who understands the inter-relationships between non-invasive imaging, coronary angiography and revascularization.
Chief Medical Officer, Cleerly Inc.
Dr. Earls is a Professor of Radiology at George Washington University Hospital and a leader within the field of Radiology in applications of advanced imaging technologies in cardiovascular care.
Our conversation covered multiple viewpoints on heart attack prevention, including the comparative accuracy of CAC and AI-based cardiac imaging and the benefits of a combined approach.
What role does prevention play in cardiology today, and how is CAC used to assess heart disease risk?
How AI-enabled CCTA helps determine the age of individual plaques and their natural history, identifies the level of disease burden, and guides personalized treatment.
Understanding the CAC zero score and the accuracy of using CAC versus AI-enabled CCTA to assess heart disease risk.
When used together, how can these two tests enable better heart health outcomes?
The Cleerly webinars are open to any cardiologist, radiologist or other healthcare professional with an interest in breakthrough medtech for heart disease and prevention.